HealthMore in Health→
Colorado Drug Pricing Fight Turns to Orphan Medicines
Pharmaceutical companies and patient groups are pushing to exempt orphan drugs from potential Colorado pricing limits, opening a new front in the broader debate over rare-disease treatments and affordability.
Key Takeaways
- A bill in Colorado would exempt orphan drugs from pricing caps the state might pursue.
- Pharmaceutical companies and patient groups are backing the exemption effort.
DE
DT Editorial Team··via statnews.com